NEW YORK (GenomeWeb) – Luminex said today that its NxTag Respiratory Pathogen Panel has received US Food and Drug Administration clearance. 

The panel received clearance less than 90 days from submission, following the CE Mark that Luminex received for the panel in October.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.